BRKR | Bruker Corporation Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	55.27 - 58.08
52 Week Range	48.07 - 94.86
Beta	1.18
Implied Volatility	41.35%
IV Rank	49.31%
Day's Volume	2,714,983
Average Volume	1,389,885
Shares Outstanding	151,598,000
Market Cap	8,641,086,000
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2000-08-04

Valuation
Profitability
Growth
Health
P/E Ratio	27.54
Forward P/E Ratio	25.87
EPS	2.07
1YR Price Target	90.00
Dividend Yield	0.35%
Dividend Per Share	0.20
Dividend ExDate	2023-05-31
Dividend PayDate	2023-06-16
Employees	9,707
Country	USA
Website	BRKR

Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker BioSpin Group, Bruker Calid Group, Bruker Scientific Instruments Nano, and Bruker Energy & Supercon Technologies. The Bruker BioSpin Group and Bruker Calid Group are aggregated into BSI Life Science segment for reporting purposes, and it provides the highest revenue stream to the firm. The largest proportion of Bruker's revenue comes from Europe, though the firm also has a significant presence in the United States and Asia. It has its major technical and manufacturing centers in Europe, North America, Southeast Asia, as well as sales offices throughout the world.

BRKR's peers: BIO, BIO-B, OFIX, NUVA, GKOS, HSKA, ITGR, CNMD, LIVN, IRTC, ZBH, AORT, AXGN, LUNG, ELMD, SRDX, KIDS, FNA, CERS, GMED, PHG, QDEL, SNN, STE, VREX

*Chart delayed

Analyzing fundamentals for BRKR we got that it has average fundamentals where Valuation is considered to be slightly overvalued, Profitability is poor, Growth is exceptionally good and Health is very weak. For more detailed analysis please see BRKR Fundamentals page.

Watching at BRKR technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on BRKR Technicals page.